(Q34330072)

1 August 2017

1 reference

title

Burkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis? (English)

1 reference

1 August 2017

0 references

1 reference

1 reference

1 reference

LiPuma JJ

1

1 reference

1 August 2017

publication date

1 September 2001

1 reference

Transplant Infectious Disease

1 August 2017

published in

1 reference

1 August 2017

volume

3

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

149-160

1 reference

Burkholderia cepacia. Management issues and new insights.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Pseudobacteremia caused by povidone-iodine solution contaminated with Pseudomonas cepacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Pseudomonas Species Bacteremia Caused by Contaminated Normal Human Serum Albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Antibiotic prophylaxis in cystic fibrosis: inhaled cephaloridine as an adjunct to oral cloxacillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Pseudomonas cepacia infection in cystic fibrosis: an emerging problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Burkholderia cepacia respiratory tract acquisition: epidemiology and molecular characterization of a large nosocomial outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Lack of evidence of nosocomial cross-infection by Burkholderia cepacia among Danish cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Pseudomonas cepacia: a new pathogen in patients with cystic fibrosis referred to a large centre in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Pseudomonas cepacia: pulmonary infection in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Burkholderia cepacia in cystic fibrosis. Variable disease course.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Decreased baseline beta-lactamase production and inducibility associated with increased piperacillin susceptibility of Pseudomonas cepacia isolated from children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Isolation and characterization of dihydrofolate reductase from trimethoprim-susceptible and trimethoprim-resistant Pseudomonas cepacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Longitudinal serum IgG response toPseudomonas cepacia surface antigens in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Biological activity ofBurkholderia (Pseudomonas) cepacialipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Invasion and intracellular survival of Burkholderia cepacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Intracellular survival of Burkholderia cepacia complex isolates in the presence of macrophage cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

In vitro analysis of roles of a disulfide bridge and a calcium binding site in activation of Pseudomonas sp. strain KWI-56 lipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Identification of a siderophore receptor required for ferric ornibactin uptake in Burkholderia cepacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Virulence factors of Burkholderia cepacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Lung transplantation for cystic fibrosis: special considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Should patients with cystic fibrosis infected with Burkholderia cepacia undergo lung transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Infectious complications of lung transplantation. Impact of cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Double-lung transplantation for cystic fibrosis. The Cystic Fibrosis Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Lung transplantation for cystic fibrosis: effective and durable therapy in a high-risk group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Infections in patients with cystic fibrosis following lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Pseudomonas cepacia empyema necessitatis after lung transplantation in two patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Bronchiolitis obliterans organizing pneumonia (BOOP) in lung transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Pleural complications in lung transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Nucleic Acid Homologies in the Genus Pseudomonas

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Proposal of Burkholderia gen. nov. and Transfer of Seven Species of the Genus Pseudomonas Homology Group II to the New Genus, with the Type Species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Transfer of TwoBurkholderiaand AnAlcaligenesSpecies toRalstoniaGen. Nov.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Polyphasic Taxonomy in the Genus Burkholderia Leading to an Emended Description of the Genus and Proposition of Burkholderia vietnamiensis sp. nov. for N2-Fixing Isolates from Rice in Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Ribotype Stability of Serial Pulmonary Isolates of Pseudomonas cepacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Antibody Response to Burkholderia cepacia in Patients with Cystic Fibrosis Colonized with Burkholderia cepacia and Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Post-transplantation survival of cystic fibrosis patients infected with Pseudomonas cepacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

Necrotizing Pneumonitis Due to the Pseudomonad Eugonic Oxidizer — Group I

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Pseudomonas cepacia (multivorans) septicaemia in an intensive-care unit

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Pseudobacteremia attributed to contamination of povidone-iodine with Pseudomonas cepacia.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Transmission of Pseudomonas cepacia among cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Transmissibility of Pseudomonas cepacia Infection in Clinic Patients and Lung-Transplant Recipients with Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

1 reference

7 January 2021

Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Pulmonary function, serum markers of inflammation, and IgG antibodies to core lipopolysaccharide of Burkholderia cepacia in adults with cystic fibrosis, following colonization with Burkholderia cepacia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Pseudomonas cepacia in inpatients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Induction of biologically active interleukin-8 from lung epithelial cells by Burkholderia (Pseudomonas) cepacia products.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

The dsbB gene product is required for protease production by Burkholderia cepacia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

A nonhemolytic phospholipase C from Burkholderia cepacia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Structural elucidation of a novel exopolysaccharide produced by a mucoid clinical isolate of Burkholderia cepacia. Characterization of a trisubstituted glucuronic acid residue in a heptasaccharide repeating unit

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Quorum sensing in Burkholderia cepacia: identification of the LuxRI homologs CepRI

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Successful heart-lung transplantation for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Technique of successful clinical double-lung transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Experience with pediatric lung transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Pseudomonas cepacia in lung transplant recipients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

A decade of lung transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Double-lung transplantation in mechanically ventilated patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

The potential of nosocomial transmission of Pseudomonas cepacia exists at cardiopulmonary transplant centers

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Subdural empyema due to Burkholderia cepacia: an unusual complication after lung transplantation for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV).

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

PCR ribotyping and endonuclease subtyping in the epidemiology of Burkholderia cepacia infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Transmission and prevalence of Burkholderia cepacia in Welsh cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Burkholderia cepacia epidemiology and pathogenesis: implications for infection control.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Molecular epidemiology of Burkholderia cepacia in two Australian cystic fibrosis centres

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Pseudomonas cepacia in the sputum of cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Lung transplantation for cystic fibrosis; the effect of B cepacia genomovars on post transplant outcomes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCR

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

Comparison of culture and PCR for detection of Burkholderia cepacia in sputum samples of patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003149.X

7 January 2021

10.1034/J.1399-3062.2001.003003149.X

Identifiers

DOI

1 reference

1 August 2017

1 reference